Q2 Presentation and Q&A
How does this Q&A work:
This company invites all interested, both current investors and potential investors to participate in this event, ask questions directly on this page before the event starts and upvote those questions you would like addressed.
The company will address as many questions as possible, and focus on those questions most wanted by investors.
Speakers at this event:
9 Questions
Aug. 29, 2024
What happens to the warrants if the stock is not traded in the range explained?
Aug. 29, 2024
What is the reasons for larger companies to buy into some your competitors instead of you? Is it the pipeline, the phases they are in or the technology or do you know the reasons?
Aug. 29, 2024
You have probably explained this before, but there are other targeted radiation companies in the world. What makes you different from those other companies also those that have been acquired by larger corporations?
Aug. 29, 2024
Do you an update on the M&A market. We have been talking about a high interest for some time. Do you still see larger companies with high interest in this field?
Aug. 28, 2024
Redeye has calculated a fair value of around 27 DKK per share and have only included one uTREAT area. Since the stock is far away from this, why do you think investors are not willing to pay a higher price at the moment?
Aug. 28, 2024
What will you do to increase wareness and attract more investors for better success with the TO2 and TO3 and increased share price?
Aug. 28, 2024
Can you explain the TO2 and TO3 as I understand it, the stock price has to move up a certain amount over the next period for the TO2 and TO3 to be of extra value for investors, or is that not true?
Aug. 28, 2024
Are you seeing more interest from institutional investors after securing some funding and after the market is beginning to loosen up a bit again?
Aug. 28, 2024
If you present preliminary data from your study already in Q4 will you then be subject to another milestone payment from Curium?